Standout Papers

Interleukin 10 is a potent growth and differentiation factor for activated human B ... 1988 2026 2000 2013 1.1k
  1. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. (1992)
    F Rousset, Elisabeth Garcia et al. Proceedings of the National Academy of Sciences
  2. The CD40 Antigen and its Ligand (1994)
    Jacques Banchereau, Fernando Bazán et al. Annual Review of Immunology
  3. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. (1988)
    Jérôme Pène, F Rousset et al. Proceedings of the National Academy of Sciences
  4. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. (1992)
    Thierry Defrance, Béatrice Vanbervliet et al. The Journal of Experimental Medicine

Immediate Impact

20 by Nobel laureates 49 from Science/Nature 100 standout
Sub-graph 1 of 17

Citing Papers

The microbiota regulates type 2 immunity through RORγt + T cells
2015 StandoutScienceNobel
Preferential Generation of Follicular B Helper T Cells from Foxp3 + T Cells in Gut Peyer's Patches
2009 StandoutScienceNobel
6 intermediate papers

Works of F Rousset being referenced

Growing human B lymphocytes in the CD40 system
1991 Nature
Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40
1991 Science
and 3 more

Author Peers

Author Last Decade Papers Cites
F Rousset 5512 923 955 1200 1138 68 8.4k
Marika Sarfati 4766 694 755 1132 1454 127 7.3k
Sandra Zurawski 6549 245 1687 1265 1189 52 9.2k
B J Nickoloff 3452 327 1797 971 1568 78 6.8k
Jean‐Yves Bonnefoy 6100 1114 485 1775 2254 152 10.4k
Daniele D’Ambrosio 6122 467 386 744 1569 80 9.3k
James B. Rottman 5520 398 377 717 1121 70 8.6k
Hervé Groux 6979 270 543 905 1710 77 10.4k
Christoph Heusser 4478 1104 500 1846 1534 114 8.1k
Jérôme Pène 3035 380 812 1046 734 76 5.3k
G Delespesse 3457 1061 270 969 870 115 5.4k

All Works

Loading papers...

Rankless by CCL
2026